Jackowiak M, Buczkowski T
Oddziału Urazowo-Ortopedycznego Wojewódzkiego Szpitala Zespolonego w Toruniu.
Chir Narzadow Ruchu Ortop Pol. 1997;62(1):55-8.
The aim of this paper was to present the use of Cefamandole as one of the elements in perioperative prophylactics in total hip replacement. One hundred patients operated between 1993 and 1995 were followed-up for mean 13.5 months. There were 33 males and 67 females, mean age was 61.4 years. Cefamandole was administered according to fixed protocol for three days (first dose along with premedication). Mono-antibiotic therapy was sufficient in most cases. No septic complication occurred, no side-effects of Cefamandole were recorded. The patients are still being followed-up. Results achieved resemble these from the literature so conclusion can be made, that Cefamandole is safe and efficient drug for peri-operative prophylactics in total hip replacement.
本文旨在介绍头孢孟多作为全髋关节置换围手术期预防用药的一种药物的使用情况。对1993年至1995年间接受手术的100例患者进行了平均13.5个月的随访。其中男性33例,女性67例,平均年龄61.4岁。头孢孟多按照固定方案给药三天(首剂与术前用药同时使用)。在大多数情况下,单药抗生素治疗就足够了。未发生败血症并发症,未记录到头孢孟多的副作用。这些患者仍在接受随访。所取得的结果与文献中的结果相似,因此可以得出结论,头孢孟多是全髋关节置换围手术期预防用药的一种安全有效的药物。